Skip to main content
Top
Published in: Journal of Endocrinological Investigation 1/2024

Open Access 14-06-2023 | Cushing's Syndrome | Original Article

Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study

Authors: M. Detomas, T. Deutschbein, M. Tamburello, I. Chifu, O. Kimpel, S. Sbiera, M. Kroiss, M. Fassnacht, B. Altieri

Published in: Journal of Endocrinological Investigation | Issue 1/2024

Login to get access

Abstract

Context

Cushing syndrome (CS) is associated with different hematological abnormalities. Nevertheless, conflicting data about erythropoiesis in CS have been reported. Furthermore, it is unclear whether CS sex and subtype-specific alterations in red blood cells (RBC) parameters are present.

Objective

To investigate sex and subtype-specific changes in RBC in patients with CS at initial diagnosis and after remission.

Design

Retrospective, monocentric study including 210 patients with CS (women, n = 162) matched 1:1 for sex and age to patients with pituitary microadenomas or adrenal incidentalomas (both hormonally inactive). RBC parameters were evaluated at initial diagnosis and after remission.

Results

Women with CS had higher hematocrit (median 42.2 vs 39.7%), hemoglobin (14.1 vs 13.4 g/dl) and mean corpuscular volume (MCV) (91.2 vs 87.9 fl) compared to the controls (all p < 0.0001). Women with Cushing disease (CD) showed higher hematocrit, RBC and hemoglobin levels than those with ectopic Cushing (ECS) (all p < 0.005). Men with CS had lower hematocrit (42.9 vs 44.7%), RBC count (4.8 vs 5.1n*106/µl) and hemoglobin (14.2 vs 15.4 g/dl), but higher MCV (90.8 vs 87.5 fl) than controls (all p < 0.05). In men with CS, no subtype-specific differences were identified. Three months after remission hemoglobin decreased in both sexes.

Conclusion

CS is characterized by sexual and subtype-specific differences in RBC parameters. Compared to controls, women with CS showed higher hematocrit/hemoglobin levels, whereas men had lower hematocrit/hemoglobin, which further decreased directly after remission. Therefore, anemia should be considered as complication of CS in men. In women, differences in RBC parameters may help to differentiate CD from ECS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing’s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611–629CrossRefPubMed Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing’s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611–629CrossRefPubMed
2.
go back to reference Detomas M, Altieri B, Chifu I, Remde H, Zhou X, Landwehr LS, Sbiera S, Kroiss M, Fassnacht M, Deutschbein T (2022) Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism. Eur J Endocrinol 187(3):439–449CrossRefPubMed Detomas M, Altieri B, Chifu I, Remde H, Zhou X, Landwehr LS, Sbiera S, Kroiss M, Fassnacht M, Deutschbein T (2022) Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism. Eur J Endocrinol 187(3):439–449CrossRefPubMed
3.
go back to reference Bauer A, Tronche F, Wessely O, Kellendonk C, Reichardt HM, Steinlein P, Schutz G, Beug H (1999) The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 13(22):2996–3002CrossRefPubMedPubMedCentral Bauer A, Tronche F, Wessely O, Kellendonk C, Reichardt HM, Steinlein P, Schutz G, Beug H (1999) The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 13(22):2996–3002CrossRefPubMedPubMedCentral
4.
go back to reference Hattangadi SM, Wong P, Zhang L, Flygare J, Lodish HF (2011) From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood 118(24):6258–6268CrossRefPubMedPubMedCentral Hattangadi SM, Wong P, Zhang L, Flygare J, Lodish HF (2011) From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood 118(24):6258–6268CrossRefPubMedPubMedCentral
5.
go back to reference Varricchio L, Geer EB, Martelli F, Mazzarini M, Funnell A, Bieker JJ, Papayannopoulou T, Migliaccio AR (2022) Hypercortisolemic Cushing’s patients possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis. Haematologica 108:1053–1067CrossRefPubMedCentral Varricchio L, Geer EB, Martelli F, Mazzarini M, Funnell A, Bieker JJ, Papayannopoulou T, Migliaccio AR (2022) Hypercortisolemic Cushing’s patients possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis. Haematologica 108:1053–1067CrossRefPubMedCentral
6.
go back to reference Baez-Villasenor J, Rath CE, Finch CA (1948) The blood picture in Addison’s disease. Blood 3(7):769–773CrossRefPubMed Baez-Villasenor J, Rath CE, Finch CA (1948) The blood picture in Addison’s disease. Blood 3(7):769–773CrossRefPubMed
7.
go back to reference Ambrogio AG, De Martin M, Ascoli P, Cavagnini F, Pecori GF (2014) Gender-dependent changes in haematological parameters in patients with Cushing’s disease before and after remission. Eur J Endocrinol 170(3):393–400CrossRefPubMed Ambrogio AG, De Martin M, Ascoli P, Cavagnini F, Pecori GF (2014) Gender-dependent changes in haematological parameters in patients with Cushing’s disease before and after remission. Eur J Endocrinol 170(3):393–400CrossRefPubMed
8.
go back to reference Gursoy A, Dogruk Unal A, Ayturk S, Karakus S, Nur Izol A, Bascil Tutuncu N, Guvener DN (2006) Polycythemia as the first manifestation of Cushing’s disease. J Endocrinol Invest 29(8):742–744CrossRefPubMed Gursoy A, Dogruk Unal A, Ayturk S, Karakus S, Nur Izol A, Bascil Tutuncu N, Guvener DN (2006) Polycythemia as the first manifestation of Cushing’s disease. J Endocrinol Invest 29(8):742–744CrossRefPubMed
9.
go back to reference Dusek T, Kastelan D, Solak M, Basic Kinda S, Aganovic I, Korsic M (2008) Polycythemia as the first manifestation of Cushing’s disease. J Endocrinol Invest 31(10):940CrossRefPubMed Dusek T, Kastelan D, Solak M, Basic Kinda S, Aganovic I, Korsic M (2008) Polycythemia as the first manifestation of Cushing’s disease. J Endocrinol Invest 31(10):940CrossRefPubMed
10.
go back to reference Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526–1540CrossRefPubMedPubMedCentral Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526–1540CrossRefPubMedPubMedCentral
11.
go back to reference Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD et al (2021) Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847–875CrossRefPubMedPubMedCentral Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD et al (2021) Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847–875CrossRefPubMedPubMedCentral
12.
go back to reference Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1–G34CrossRefPubMed Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1–G34CrossRefPubMed
13.
go back to reference Travison TG, Vesper HW, Orwoll E, Wu F, Kaufman JM, Wang Y, Lapauw B, Fiers T, Matsumoto AM, Bhasin S (2017) Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab 102(4):1161–1173CrossRefPubMedPubMedCentral Travison TG, Vesper HW, Orwoll E, Wu F, Kaufman JM, Wang Y, Lapauw B, Fiers T, Matsumoto AM, Bhasin S (2017) Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab 102(4):1161–1173CrossRefPubMedPubMedCentral
14.
go back to reference Detomas M, Altieri B, Deutschbein T, Fassnacht M, Dischinger U (2022) Metyrapone versus osilodrostat in the short-term therapy of endogenous Cushing’s syndrome: results from a single center cohort study. Front Endocrinol (Lausanne) 13:903545CrossRefPubMed Detomas M, Altieri B, Deutschbein T, Fassnacht M, Dischinger U (2022) Metyrapone versus osilodrostat in the short-term therapy of endogenous Cushing’s syndrome: results from a single center cohort study. Front Endocrinol (Lausanne) 13:903545CrossRefPubMed
15.
go back to reference Byron JW (1970) Effect of steroids on the cycling of haemopoietic stem cells. Nature 228(5277):1204CrossRefPubMed Byron JW (1970) Effect of steroids on the cycling of haemopoietic stem cells. Nature 228(5277):1204CrossRefPubMed
16.
go back to reference Fonseca R, Rajkumar SV, White WL, Tefferi A, Hoagland HC (1998) Anemia after orchiectomy. Am J Hematol 59(3):230–233CrossRefPubMed Fonseca R, Rajkumar SV, White WL, Tefferi A, Hoagland HC (1998) Anemia after orchiectomy. Am J Hematol 59(3):230–233CrossRefPubMed
17.
go back to reference Zilio M, Barbot M, Ceccato F, Camozzi V, Bilora F, Casonato A, Frigo AC, Albiger N, Daidone V, Mazzai L et al (2014) Diagnosis and complications of Cushing’s disease: gender-related differences. Clin Endocrinol (Oxf) 80(3):403–410CrossRefPubMed Zilio M, Barbot M, Ceccato F, Camozzi V, Bilora F, Casonato A, Frigo AC, Albiger N, Daidone V, Mazzai L et al (2014) Diagnosis and complications of Cushing’s disease: gender-related differences. Clin Endocrinol (Oxf) 80(3):403–410CrossRefPubMed
18.
go back to reference Liu X, Zhu X, Zeng M, Zhuang Y, Zhou Y, Zhang Z, Yang Y, Wang Y, Ye H, Li Y (2015) Gender-specific differences in clinical profile and biochemical parameters in patients with Cushing’s disease: a single center experience. Int J Endocrinol 2015:949620CrossRefPubMedPubMedCentral Liu X, Zhu X, Zeng M, Zhuang Y, Zhou Y, Zhang Z, Yang Y, Wang Y, Ye H, Li Y (2015) Gender-specific differences in clinical profile and biochemical parameters in patients with Cushing’s disease: a single center experience. Int J Endocrinol 2015:949620CrossRefPubMedPubMedCentral
19.
go back to reference Huan C, Qu Y, Ren Z (2014) Gender differences in presentation and outcome of patients with Cushing’s disease in Han Chinese. Biomed Mater Eng 24(6):3439–3446PubMed Huan C, Qu Y, Ren Z (2014) Gender differences in presentation and outcome of patients with Cushing’s disease in Han Chinese. Biomed Mater Eng 24(6):3439–3446PubMed
20.
go back to reference Deutschbein T, Reimondo G, Di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA, Nekic AB, Debono M, Lardo P, Ceccato F et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol 10(7):499–508CrossRefPubMedPubMedCentral Deutschbein T, Reimondo G, Di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA, Nekic AB, Debono M, Lardo P, Ceccato F et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol 10(7):499–508CrossRefPubMedPubMedCentral
21.
go back to reference Stellacci E, Di Noia A, Di Baldassarre A, Migliaccio G, Battistini A, Migliaccio AR (2009) Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells. Exp Hematol 37(5):559–572CrossRefPubMedPubMedCentral Stellacci E, Di Noia A, Di Baldassarre A, Migliaccio G, Battistini A, Migliaccio AR (2009) Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells. Exp Hematol 37(5):559–572CrossRefPubMedPubMedCentral
23.
go back to reference Maceckova Z, Kubickova A, De Sanctis JB, Hajduch M (2022) Effect of glucocorticosteroids in Diamond–Blackfan anaemia: maybe not as elusive as it seems. Int J Mol Sci 23(3):1886CrossRefPubMedPubMedCentral Maceckova Z, Kubickova A, De Sanctis JB, Hajduch M (2022) Effect of glucocorticosteroids in Diamond–Blackfan anaemia: maybe not as elusive as it seems. Int J Mol Sci 23(3):1886CrossRefPubMedPubMedCentral
24.
go back to reference Barbui T, Carobbio A, Rumi E, Finazzi G, Gisslinger H, Rodeghiero F, Randi ML, Rambaldi A, Gisslinger B, Pieri L et al (2014) In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood 124(19):3021–3023CrossRefPubMed Barbui T, Carobbio A, Rumi E, Finazzi G, Gisslinger H, Rodeghiero F, Randi ML, Rambaldi A, Gisslinger B, Pieri L et al (2014) In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood 124(19):3021–3023CrossRefPubMed
25.
go back to reference Badesha AS, Khan T, Abdellatif E (2022) Iliac vein deep vein thrombosis as an atypical presentation of an adrenocortical carcinoma. BMJ Case Rep 15(5):e248708CrossRefPubMed Badesha AS, Khan T, Abdellatif E (2022) Iliac vein deep vein thrombosis as an atypical presentation of an adrenocortical carcinoma. BMJ Case Rep 15(5):e248708CrossRefPubMed
26.
go back to reference Durmusoglu J, Timmers H, van Houten P, Langenhuijsen JF, Hermus A, van de Ven AC (2020) Venous thromboembolism in patients with adrenocortical carcinoma after surgery. Endocr Connect 9(9):874–881CrossRefPubMedPubMedCentral Durmusoglu J, Timmers H, van Houten P, Langenhuijsen JF, Hermus A, van de Ven AC (2020) Venous thromboembolism in patients with adrenocortical carcinoma after surgery. Endocr Connect 9(9):874–881CrossRefPubMedPubMedCentral
27.
go back to reference Halperin R, Ahron-Hananel G, Badarna M, Greidinger D, Uri I, Percik R, Tirosh A (2021) Plasma hemoglobin and red blood cell mass levels as dynamic prognostic markers for progression and survival in pancreatic neuroendocrine tumors. Horm Metab Res 53(12):810–817CrossRefPubMed Halperin R, Ahron-Hananel G, Badarna M, Greidinger D, Uri I, Percik R, Tirosh A (2021) Plasma hemoglobin and red blood cell mass levels as dynamic prognostic markers for progression and survival in pancreatic neuroendocrine tumors. Horm Metab Res 53(12):810–817CrossRefPubMed
28.
go back to reference Gvirtzman R, Livovsky DM, Tahover E, Goldin E, Koslowsky B (2021) Anemia can predict the prognosis of colorectal cancer in the pre-operative stage: a retrospective analysis. World J Surg Oncol 19(1):341CrossRefPubMedPubMedCentral Gvirtzman R, Livovsky DM, Tahover E, Goldin E, Koslowsky B (2021) Anemia can predict the prognosis of colorectal cancer in the pre-operative stage: a retrospective analysis. World J Surg Oncol 19(1):341CrossRefPubMedPubMedCentral
29.
go back to reference Vignjevic Petrinovic S, Jaukovic A, Milosevic M, Bugarski D, Budec M (2022) Targeting stress erythropoiesis pathways in cancer. Front Physiol 13:844042CrossRefPubMedPubMedCentral Vignjevic Petrinovic S, Jaukovic A, Milosevic M, Bugarski D, Budec M (2022) Targeting stress erythropoiesis pathways in cancer. Front Physiol 13:844042CrossRefPubMedPubMedCentral
30.
go back to reference Cheng J, Patel G, Dawood A, Aqeel A (2022) Gastric and duodenal neuroendocrine tumor incidentally found on endoscopy during the evaluation of iron-deficiency anemia. Cureus 14(2):e22208PubMedPubMedCentral Cheng J, Patel G, Dawood A, Aqeel A (2022) Gastric and duodenal neuroendocrine tumor incidentally found on endoscopy during the evaluation of iron-deficiency anemia. Cureus 14(2):e22208PubMedPubMedCentral
31.
go back to reference Xu B, Wang Y, Li X, Lin J (2017) Nonfunctional pancreatic neuroendocrine tumor masked as anemia: a case report. Medicine (Baltimore) 96(27):e7441CrossRefPubMed Xu B, Wang Y, Li X, Lin J (2017) Nonfunctional pancreatic neuroendocrine tumor masked as anemia: a case report. Medicine (Baltimore) 96(27):e7441CrossRefPubMed
32.
go back to reference Hatipoglu E, Caglar AS, Caglar E, Ugurlu S, Tuncer M, Kadioglu P (2015) Peptic ulcer disease in endogenous hypercortisolism: myth or reality? Endocrine 50(2):489–495CrossRefPubMed Hatipoglu E, Caglar AS, Caglar E, Ugurlu S, Tuncer M, Kadioglu P (2015) Peptic ulcer disease in endogenous hypercortisolism: myth or reality? Endocrine 50(2):489–495CrossRefPubMed
33.
go back to reference Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH (2003) Hepatic steatosis in Cushing’s syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 149(6):543–548CrossRefPubMed Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH (2003) Hepatic steatosis in Cushing’s syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 149(6):543–548CrossRefPubMed
34.
go back to reference Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y, Inoue M, Sagayama A, Umeki K (2001) Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 138(5):332–337CrossRefPubMed Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y, Inoue M, Sagayama A, Umeki K (2001) Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 138(5):332–337CrossRefPubMed
35.
go back to reference Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M, Connor Westfall J, Bae H, Gordeuk V, Bhasin S (2014) Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci 69(6):725–735CrossRefPubMed Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M, Connor Westfall J, Bae H, Gordeuk V, Bhasin S (2014) Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci 69(6):725–735CrossRefPubMed
36.
go back to reference Santos A, Resmini E, Martinez Momblan MA, Valassi E, Martel L, Webb SM (2019) Quality of life in patients with Cushing’s disease. Front Endocrinol (Lausanne) 10:862CrossRefPubMed Santos A, Resmini E, Martinez Momblan MA, Valassi E, Martel L, Webb SM (2019) Quality of life in patients with Cushing’s disease. Front Endocrinol (Lausanne) 10:862CrossRefPubMed
37.
go back to reference Luton JP, Thieblot P, Valcke JC, Mahoudeau JA, Bricaire H (1977) Reversible gonadotropin deficiency in male Cushing’s disease. J Clin Endocrinol Metab 45(3):488–495CrossRefPubMed Luton JP, Thieblot P, Valcke JC, Mahoudeau JA, Bricaire H (1977) Reversible gonadotropin deficiency in male Cushing’s disease. J Clin Endocrinol Metab 45(3):488–495CrossRefPubMed
Metadata
Title
Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study
Authors
M. Detomas
T. Deutschbein
M. Tamburello
I. Chifu
O. Kimpel
S. Sbiera
M. Kroiss
M. Fassnacht
B. Altieri
Publication date
14-06-2023
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 1/2024
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02128-x

Other articles of this Issue 1/2024

Journal of Endocrinological Investigation 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine